Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Alexandrou

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 30, 2006
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinomaE Mylona, P Alexandrou, A Mpakali, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2003
The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cellsL Nakopoulou, I Giannopoulou, A Ch Lazaris, et al.
Climacteric : the Journal of the International Menopause Society|September 14, 2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal womenN C Keramaris, G E Christodoulakos, I V Lambrinoudaki, et al.
Neoplasma|May 10, 2017
High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinomaC Giaginis, D Karandrea, P Alexandrou, et al.
Maturitas|January 1, 2008
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifeneIrene V Lambrinoudaki, George E Christodoulakos, Emmanuel V Economou, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumorsA Armakolas, A Dimakakos, C Loukogiannaki, et al.
Maturitas|September 6, 2005
A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thicknessGeorge E Christodoulakos, Dimitrios S Botsis, Irene V Lambrinoudaki, et al.
Menopause (New York, N.Y.)|July 31, 2008
CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal womenIrene V Lambrinoudaki, George I Kaparos, Sofia A Vlachou, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 30, 2006
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinomaE Mylona, P Alexandrou, A Mpakali, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2003
The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cellsL Nakopoulou, I Giannopoulou, A Ch Lazaris, et al.
Climacteric : the Journal of the International Menopause Society|September 14, 2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal womenN C Keramaris, G E Christodoulakos, I V Lambrinoudaki, et al.
Neoplasma|May 10, 2017
High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinomaC Giaginis, D Karandrea, P Alexandrou, et al.
Maturitas|January 1, 2008
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifeneIrene V Lambrinoudaki, George E Christodoulakos, Emmanuel V Economou, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumorsA Armakolas, A Dimakakos, C Loukogiannaki, et al.
Maturitas|September 6, 2005
A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thicknessGeorge E Christodoulakos, Dimitrios S Botsis, Irene V Lambrinoudaki, et al.
Menopause (New York, N.Y.)|July 31, 2008
CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal womenIrene V Lambrinoudaki, George I Kaparos, Sofia A Vlachou, et al.
Pageof 2